Cardiovascular Systems (NASDAQ:CSII) Trading Down 5.7%
Cardiovascular Systems (NASDAQ:CSII) Trading Down 5.7%
Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating)'s share price dropped 5.7% during mid-day trading on Friday . The stock traded as low as $13.28 and last traded at $13.29. Approximately 1,185 shares were traded during trading, a decline of 100% from the average daily volume of 283,807 shares. The stock had previously closed at $14.10.
納斯達克(代碼：CSII-GET Rating)週五午盤交易中，心血管系統公司股價下跌5.7%。該股最低跌至13.28美元，最新報13.29美元。該股當日成交量約為1,185股，較平均日成交量283,807股下降一倍。此前該股收盤報14.10美元。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
CSII has been the topic of several research reports. StockNews.com initiated coverage on shares of Cardiovascular Systems in a research report on Wednesday, October 12th. They set a "hold" rating on the stock. Lake Street Capital initiated coverage on shares of Cardiovascular Systems in a research report on Wednesday, December 14th. They set a "buy" rating and a $25.00 price objective on the stock. Finally, Barclays assumed coverage on shares of Cardiovascular Systems in a report on Wednesday. They issued an "equal weight" rating and a $15.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $20.00.
CSII一直是幾份研究報告的主題。StockNews.com在10月12日星期三的一份研究報告中啟動了對心血管系統股票的報道。他們對該股設定了“持有”評級。Lake Street Capital在12月14日星期三的一份研究報告中啟動了對心血管系統股票的報道。他們為該股設定了“買入”評級和25.00美元的目標價。最後，巴克萊在週三的一份報告中對心血管系統的股票進行了報道。他們對該股給予了“同等權重”的評級和15.00美元的目標價。一位股票研究分析師對該股的評級為賣出，兩位分析師給出了持有評級，兩位分析師給出了該公司的買入評級。根據MarketBeat.com的數據，該股的平均評級為持有，平均目標價為20.00美元。
Cardiovascular Systems Trading Up 0.2 %
心血管系統公司股價上漲0.2%
The firm has a market cap of $557.84 million, a PE ratio of -13.32 and a beta of 0.86. The company's fifty day moving average price is $14.08 and its two-hundred day moving average price is $14.40. The company has a quick ratio of 5.20, a current ratio of 6.22 and a debt-to-equity ratio of 0.08.
該公司市值為5.5784億美元，市盈率為-13.32，貝塔係數為0.86。該公司的50日移動均線價格為14.08美元，200日移動均線價格為14.40美元。該公司的速動比率為5.20，流動比率為6.22，債務權益比為0.08。
Institutional Trading of Cardiovascular Systems
心血管系統的制度性交易
A number of institutional investors have recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp boosted its holdings in Cardiovascular Systems by 0.4% during the third quarter. Bank of New York Mellon Corp now owns 360,772 shares of the medical device company's stock worth $4,999,000 after buying an additional 1,595 shares in the last quarter. Teachers Retirement System of The State of Kentucky purchased a new stake in Cardiovascular Systems during the third quarter worth about $150,000. M&T Bank Corp boosted its holdings in Cardiovascular Systems by 16.7% during the third quarter. M&T Bank Corp now owns 46,606 shares of the medical device company's stock worth $647,000 after buying an additional 6,673 shares in the last quarter. Neuberger Berman Group LLC boosted its holdings in Cardiovascular Systems by 6.5% during the third quarter. Neuberger Berman Group LLC now owns 859,542 shares of the medical device company's stock worth $11,920,000 after buying an additional 52,815 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. raised its position in Cardiovascular Systems by 9.8% during the third quarter. Jacobs Levy Equity Management Inc. now owns 171,062 shares of the medical device company's stock worth $2,371,000 after acquiring an additional 15,261 shares during the last quarter. Hedge funds and other institutional investors own 86.61% of the company's stock.
一些機構投資者最近增持或減持了該股。紐約梅隆銀行(Bank Of New York Mellon Corp)第三季度將其在心血管系統公司的持股增加了0.4%。紐約梅隆銀行(Bank Of New York Mellon Corp)目前持有360,772股這家醫療設備公司的股票，價值4,999,000美元，此前該公司在上個季度又購買了1,595股。肯塔基州教師退休系統在第三季度購買了心血管系統公司的新股份，價值約15萬美元。M&T Bank Corp在第三季度增持了16.7%的心血管系統股份。M&T銀行(M&T Bank Corp)目前持有46,606股這家醫療設備公司的股票，價值647,000美元，此前該公司在上個季度又購買了6,673股。Neuberger Berman Group LLC在第三季度將其在心血管系統公司的持股增加了6.5%。Neuberger Berman Group LLC現在持有這家醫療設備公司859,542股股票，價值11,920,000美元，上個季度又購買了52,815股。最後，雅各布斯·利維股票管理公司在第三季度將其在心血管系統公司的地位提高了9.8%。雅各布斯·利維股權管理公司(Jacobs Levy Equity Management Inc.)目前持有這家醫療設備公司171,062股股票，價值2,371,000美元，此前該公司在上個季度增持了15,261股。對衝基金和其他機構投資者持有該公司86.61%的股票。
About Cardiovascular Systems
關於心血管系統
(Get Rating)
(獲取評級)
Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
心血管系統公司是一家醫療技術公司，在美國和國際上開發和銷售治療外周和冠狀動脈疾病的解決方案。該公司提供外周動脈疾病產品，包括基於導管的平臺，用於治療膝蓋以上和膝蓋以下的各種斑塊類型，包括鈣化斑塊，以及解決與手術、導管和藥物治療替代方案相關的各種限制；以及外周支持產品。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- MarketBeat: Week in Review 12/19 – 12/23
- These Steelmakers Deserve A Place On Your 2023 Watch List
- Inflation Cools, Where Does The S&P 500 Go Now
- Cintas Beats Inflation With Operating Leverage
- Your Decision to Buy Palantir May Simply Be a Matter of Time
- 免費獲取StockNews.com心血管系統研究報告(CSII)
- MarketBeat：回顧一週12/19-12/23
- 這些鋼鐵製造商理應在2023年觀察名單上佔有一席之地
- 通脹降温，標普500指數何去何從
- Cintas以經營槓桿擊敗通脹
- 你買下Palantir的決定可能只是個時間問題
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受《每日心血管系統》新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對心血管系統和相關公司的最新新聞和分析師評級的每日簡要摘要。